Andy Coravos left a promising career at a top private equity firm to follow her passion and pursue intensive training as a software developer; she now works on the frontier of engineering and medicine as CEO and co-founder of Elektra Labs, focused on the use of digital measures to support clinical research, and the generation of the sort of quality evidence she believes distinguishes “digital health” from “digital medicine.”

The daughter of a dentist and a nurse, Andy grew up with an exposure to healthcare, and an interest in making things, but found herself pursuing economics at college.  After several years at McKinsey, and a stint at the private equity firm KKR, where she was on a promising career trajectory, Andy decided she owed it to herself to pursue what she viewed as her true passion, and she enrolled in an intense coding bootcamp.

This was a profound inflection point in her life, as she has remained closely engaged with tech ever since, including while at Harvard Business School, through stints as a software engineer at Instacart and Akili Interactive, and now at Elektra Labs.  Andy has become an articulate thought leader, helping integrate business, technology, and healthcare in a deeply knowledgeable and considered fashion. We are delighted to have Andy on our show today!

Today’s episode is sponsored by IDEA Pharma, the industry’s leading path-to-market strategy practice, bring more great medicines to patients.  You can find them at:
www.ideapharma.com

Tags: andy coravos, biomed, david shaywitz, digital health, dnanexus, elektra labs, epatient, genomics, health startup, health technology, human genome, lisa suennen, medical research, precision medicine, tech tonics, technology and health, venture valkyrie
 
Posted in: Audio Podcast, Healthcare, Tech Tonics, Technology